About this trial
Randomized clinical trial to evaluate the visual performance of enhanced monofocal and extended depth-of-field intraocular lenses
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with bilateral cataracts at different stages of development.
Patients with functional visual demands.
Age between 45 and 80 years.
Male or female sex.
Disqualifiers
Vitreous loss.
Pupillary trauma.
Factors likely to affect the medium-term performance of the intraocular lens: Zonular damage, Capsulorhexis tear or injury, Capsular rupture, Endothelial damage.
Trial design
Parallel
Treatments tested in this trial
Intraocular lens
DeviceImplantation of intraocular lens
Treatment groups
6
Treatment groupsSee each treatment group below.
Trial outcomes
Primary outcomes
Visual acuity at different distances
Far vision, intermediate vision, near vision
Dysphotopsias
Dysphotopsias after the IOL implantation
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: